What are Teladoc Health's total assets?

Teladoc Health (TDOC) holds $2.8B in total assets, down 18.5% year over year.

How much debt does Teladoc Health have?

Teladoc Health carries $42.2M in total debt against $1.3B of shareholders' equity, a debt-to-equity ratio of 0.03.

How much cash does Teladoc Health have?

Teladoc Health holds $750.7M in cash and equivalents.

Can Teladoc Health cover its short-term obligations?

Its current ratio is 2.80 — current assets exceed current liabilities.

Where does Teladoc Health's balance sheet data come from?

Every line is extracted from Teladoc Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Teladoc Health TDOC Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$781.08M-39.8%	$1.3B+15.5%	$1.12B+22.4%	$918.18M+2.8%
Accounts receivable, net	$192.83M-10.0%	$214.15M-1.5%	$217.42M+3.3%	$210.55M+24.6%
Inventories	$38.2M+0.2%	$38.14M+29.2%	$29.51M-47.6%	$56.34M-22.9%
Work in process	$502K-16.3%	$600K+101%	$299K-30.9%	$433K—
Finished goods	$23.92M+3.6%	$23.08M+16.1%	$19.88M-37.8%	$31.98M—
Prepaid expenses and other current assets	$107.02M-5.5%	$113.3M-4.3%	$118.44M-9.1%	$130.31M+49.1%
Total current assets	$1.12B-32.7%	$1.66B+11.7%	$1.49B+13.2%	$1.32B+7.3%
Property and equipment, net	$26.97M-8.5%	$29.49M-7.9%	$32.03M+8.1%	$29.64M+8.8%
Accumulated depreciation	$1.5B+2,000%	$71.36M+19.4%	$59.74M-89.8%	$584.49M—
Operating lease right-of-use assets	$26.12M-3.6%	$27.09M+42,799,367,988%	$0.06+4.1%	$0.06-100.0%
Goodwill	$283.19M0.0%	$283.19M-73.6%	$1.07B0.0%	$1.07B-92.6%
Intangible assets, net	$1.3B-9.4%	$1.43B-14.7%	$1.68B-8.7%	$1.84B-3.8%
Other non-current assets	$105.8M+29.8%	$81.49M+1.5%	$80.26M+65.3%	$48.54M+134%
Total assets	$2.86B-18.7%	$3.52B-19.9%	$4.39B+1.1%	$4.35B-75.5%
Accounts payable	$47.97M+44.8%	$33.13M-24.1%	$43.64M-8.5%	$47.69M+0.9%
Accrued expenses	$96.26M+26.3%	$76.23M-25.8%	$102.69M+25.9%	$81.55M-11.3%
Deferred revenue	$62.31M-21.4%	$79.3M-17.1%	$95.66M-6.1%	$101.83M+2,556%
Operating lease liabilities, current	$11.04M+6.8%	$10.34M-3.9%	$10.75M-20.9%	$13.59M+7.1%
Contract liabilities	$9.14M-6.6%	$9.79M-28.2%	$13.62M+14.0%	$11.95M—
Accrued interest	$1.04M-29.7%	$1.48M+0.1%	$1.48M+0.1%	$1.48M—
Claims and insurance accruals	$7.72M+0.9%	$7.65M+32.5%	$5.78M-3.4%	$5.98M—
Total current liabilities	$404.74M-57.0%	$941.54M+124%	$420.62M+5.2%	$399.77M+20.8%
Operating lease liabilities, non-current	$34.2M+6.4%	$32.14M-25.0%	$42.84M+12.6%	$38.04M-8.9%
Other non-current liabilities	$643K-10.7%	$720K-33.3%	$1.08M-33.3%	$1.62M+8.4%
Total liabilities	$1.47B-27.3%	$2.03B-2.0%	$2.07B—	——
Common stock	300M+173,310%	173K-99.9%	300M+183,949%	163K+1.9%
Additional paid-in capital	$17.85B+0.5%	$17.76B+1.0%	$17.59B+1.3%	$17.36B-0.7%
Retained earnings	-$16.43B-1.2%	-$16.23B-6.6%	-$15.23B-1.5%	-$15.01B-956%
Accumulated other comprehensive income (loss)	-$34.73M+9.5%	-$38.39M-3.8%	-$36.99M+13.5%	-$42.78M-581%
Total stockholders' equity	$1.39B-7.1%	$1.49B-35.9%	$2.33B+0.8%	$2.31B-85.6%
Total liabilities and stockholders' equity	$2.86B-18.7%	$3.52B-19.9%	$4.39B+1.1%	$4.35B-75.5%
Allowance for Doubtful Accounts	$4.03M-21.4%	$5.13M+21.1%	$4.24M-1.9%	$4.32M—
Allowance for Doubtful Accounts Receivable (Current)	$4.03M-21.4%	$5.13M+21.1%	$4.24M-1.9%	$4.32M—
Other current assets	$2.07M-26.8%	$2.83M-62.0%	$7.44M-38.5%	$12.1M—
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)	$8.83M-9.9%	$9.81M-22.4%	$12.64M-49.6%	$25.09M—
Other Receivables	$8.83M-9.9%	$9.81M-22.4%	$12.64M-49.6%	$25.09M—
Deferred Tax Assets and Other Non-Current Assets	$105.8M+512%	$17.29M+55.3%	$11.13M-77.1%	$48.54M+134%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	$103.39M—	——	——
Finite Lived Intangible Assets - Gross	$2.8B+3.7%	$2.69B+4.3%	$2.58B+6.8%	$2.42B—
Net Investment in Lease	$26.12M-3.6%	$27.09M-32.4%	$40.06M-4.2%	$41.83M-10.6%
Intangible assets — net	$1.3B-9.4%	$1.43B-14.7%	$1.68B-8.7%	$1.84B—
Other intangible assets—net	$1.3B-9.4%	$1.43B-14.7%	$1.68B-8.7%	$1.84B-3.8%
Operating lease right-of-use assets	$26.12M-3.6%	$27.09M-32.4%	$40.06M-4.2%	$41.83M-10.6%
Other non-current assets	$105.8M+29.8%	$81.49M+1.5%	$80.26M+65.3%	$48.54M+134%
Operating Lease Right-of-Use Assets in Other Assets	$26.12M-3.6%	$27.09M-32.4%	$40.06M-4.2%	$41.83M-10.6%
Software and Technology Licenses, Net	$105.8M+29.8%	$81.49M+1.5%	$80.26M+65.3%	$48.54M+134%
Accrued Manufacturing Costs	$96.26M+26.3%	$76.23M-25.8%	$102.69M+25.9%	$81.55M-11.3%
Accrued Progress Collections and Price Adjustments	$9.14M-6.6%	$9.79M-28.2%	$13.62M+14.0%	$11.95M—
Accrued expenses and other current liabilities	$198.21M-2.0%	$202.16M+13.2%	$178.63M+5.9%	$168.69M+63.9%
Compensation and benefits	$96.26M+26.3%	$76.23M-25.8%	$102.69M+25.9%	$81.55M-11.3%
Other accrued liabilities	$20.44M-25.5%	$27.43M-20.1%	$34.31M-26.5%	$46.7M—
Professional Service Fees Payable	$9.87M+5.4%	$9.36M-5.6%	$9.91M-2.4%	$10.15M—
Restructuring Reserve	$4.44M-11.8%	$5.04M+32.5%	$3.8M-6.0%	$4.04M—
Sales taxes payable	$50.43M+79.4%	$28.11M+117%	$12.93M—	——
Contract Liabilities, Non-Current	$9.14M-6.6%	$9.79M-28.2%	$13.62M+14.0%	$11.95M—
Convertible Debt (Non-Current)	$994.93M+0.4%	$991.42M-35.6%	$1.54B+0.2%	$1.54B+25.3%
Deferred revenue, net of current portion	$9.14M-6.6%	$9.79M-28.2%	$13.62M+14.0%	$11.95M—
Total debt	$45.24M-92.4%	$593.2M+1,007%	$53.59M+3.8%	$51.63M-5.2%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.00—
Common Stock Shares Issued	178.3M+2.8%	173.4M+4.0%	166.7M+2.3%	162.8M—
Additional paid-in capital	$17.85B+0.5%	$17.76B+1.0%	$17.59B+1.3%	$17.36B-0.7%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$178K+2.9%	$173K+3.6%	$167K+2.5%	$163K+1.9%
Shares Reserved for Future Issuance Under Stock Plans	——	——	——	——
Consulting fees/provider fees	$13.79M-27.3%	$18.97M+15.6%	$16.42M+0.1%	$16.41M—
Information technology	$12.17M+20.0%	$10.15M+33.4%	$7.61M—	——
Marketing and advertising	$26.71M-39.4%	$44.06M+28.0%	$34.43M-1.8%	$35.06M—
Professional service fees	$9.87M+5.4%	$9.36M-5.6%	$9.91M-2.4%	$10.15M—
Allowance for doubtful accounts	$4.03M-21.4%	$5.13M+21.1%	$4.24M-1.9%	$4.32M—
Contingent liabilities	$15.52M—	——	——	——
Net cloud computing costs	$45.4M+1.3%	$44.8M+9.0%	$41.1M+61.8%	$25.4M—
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$0—
Common stock, shares authorized (in shares)	$300M0.0%	$300M0.0%	$300M0.0%	$300M—
Common stock, shares issued (in shares)	$178.32M+2.8%	$173.41M+4.0%	$166.66M+2.3%	$162.84M—
Common Stock, Shares, Outstanding	$178.32M+2.8%	$173.41M+4.0%	$166.66M+2.3%	$162.84M—
Contract with Customer, Liability	$71.44M-19.8%	$89.08M-18.5%	$109.28M-4.0%	$113.79M—
Convertible debentures	$994.93M+0.4%	$991.42M-35.6%	$1.54B+0.2%	$1.54B+25.3%
Deferred Device Cost And Other	$45.95M-8.6%	$50.25M-0.1%	$50.28M+31.1%	$38.36M—
Deferred device and contract costs, current	$31.82M-4.1%	$33.19M+1.5%	$32.7M+9.2%	$29.96M—
Deferred Device Cost And Other Noncurrent	$14.13M-17.2%	$17.06M-2.9%	$17.57M+109%	$8.4M—
Deferred income taxes	$28.95M-41.9%	$49.85M+0.8%	$49.45M-2.9%	$50.94M-32.8%
2030 and thereafter	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	$1.5B+18.6%	$1.26B+39.3%	$906.95M+55.2%	$584.49M—
2028	——	$257.92M—	——	——
Remainder of 2026	——	——	——	——
2027	——	$313.63M—	——	——
2029	——	$186.99M—	——	——
Gross Carrying Amount	$2.8B+3.7%	$2.69B+4.3%	$2.58B+6.8%	$2.42B—
Raw materials and purchased parts	$13.78M-4.7%	$14.46M+54.8%	$9.34M-69.0%	$30.13M—
Long-Lived Assets	$26.97M-8.5%	$29.49M-7.9%	$32.03M+8.1%	$29.64M—
Staff augmentation	$5.3M+95.8%	$2.71M-36.8%	$4.29M+26.4%	$3.39M—
Prepaid expenses	$64.29M-4.7%	$67.47M+2.8%	$65.65M+3.9%	$63.16M—
Severance accrual, current	$4.44M-11.8%	$5.04M+32.5%	$3.8M+17.0%	$3.25M—
Client performance guarantees and accrued rebates	$19.73M-46.5%	$36.87M-0.2%	$36.93M—	——
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	——	$77.1M—	——	——
Aggregate fair value of awards (in shares)	——	——	——	——
Incentive stock program, shares reserved for future grants (in shares)	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Teladoc Health.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Teladoc Health's total assets?: Teladoc Health (TDOC) holds $2.8B in total assets, down 18.5% year over year.
How much debt does Teladoc Health have?: Teladoc Health carries $42.2M in total debt against $1.3B of shareholders' equity, a debt-to-equity ratio of 0.03.
How much cash does Teladoc Health have?: Teladoc Health holds $750.7M in cash and equivalents.
Can Teladoc Health cover its short-term obligations?: Its current ratio is 2.80 — current assets exceed current liabilities.
Where does Teladoc Health's balance sheet data come from?: Every line is extracted from Teladoc Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.